A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
For the treatment of all types of seizures except absence seizures.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.